MATCHPOINT THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 11 Jul 2024)
What this means for you
This application is over — abandoned 28 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97977492
- Mark type
- Stylized text
- Filed
- 11 Jan 2022
- Published for opposition
- 11 Jul 2023
- Abandoned
- 28 Jun 2024
- Attorney of record
- Joyce Liou
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; drug development and discovery services in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; scientific research in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; providing scientific research information in the field of pharmaceuticals for the treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease
Owner
- EoCys Inc., Cambridge, MA, US
- EoCys Inc., Cambridge, MA, US
Prosecution history
- 11 Jul 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 11 Jul 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Mar 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2024 — NON-FINAL ACTION E-MAILED
- 27 Mar 2024 — SU - NON-FINAL ACTION - WRITTEN
- 16 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jan 2024 — USE AMENDMENT FILED
- 16 Feb 2024 — DIVISIONAL PROCESSING COMPLETE
- 24 Jan 2024 — DIVISIONAL REQUEST RECEIVED
- 07 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jan 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 05 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED